News on Mendelian diseases, hereditary cancer, variant classification, cystic fibrosis testing and more.
Boston-based Variantyx will expand its whole-genome sequencing testing method to oncology from rare inherited and neurological disorders.
Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting.
The institute offers a rapid whole-genome sequencing test designed to diagnose infants and children suspected of having a rare genetic condition.
Later this year, the inherited cardiovascular disease clinic also plans to implement a preventive genomics program with polygenic risk score and PGx testing.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
